Welcome to our dedicated page for Wellgistics Health news (Ticker: WGRX), a resource for investors and traders seeking the latest updates and insights on Wellgistics Health stock.
Wellgistics Health, Inc. (NASDAQ: WGRX) generates news at the intersection of pharmacy distribution, health information technology, artificial intelligence, and blockchain-enabled smart contracts. Company announcements highlight how its integrated platform connects more than 6,500 pharmacies and over 200 manufacturers, combining wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services.
Recent news has focused on the rollout and evolution of the EinsteinRx™ pharmacy dispensing optimization AI platform, including its integration into pharmacy point-of-sale systems and its role as a prescription management hub. Updates also cover the development of the PharmacyChain™ blockchain-enabled smart contracts platform, supported by a license agreement with DataVault AI Inc. and the use of tokenization and quantum key encryption to create secure digital twins of pharmacy processes and transactions.
Investors and industry observers can follow coverage of therapeutic and product initiatives such as the commercial launch of the diabetes drug Brenzavvy® through the Wellgistics Pharmacy Network, distribution of GLP-1 companion muscle loss medical foods with Tollo Health, and offerings related to Long COVID, including Galectovid™ and Tollovid®. News items also address corporate developments like letters of intent for acquisitions, sponsorship of Dream Bowl 2026 and related meme coin distributions, financial results, and Nasdaq listing compliance updates.
This news feed aggregates these disclosures so readers can review earnings-related releases, product and partnership announcements, regulatory filings referenced in press releases, and strategic updates about Wellgistics Health’s role in the U.S. prescription drug and wellness markets. Regularly reviewing this page can help users understand how the company’s AI, blockchain, and distribution capabilities are being applied across its pharmacy network and manufacturer relationships.
DataMEDS AI (NASDAQ: MEDS), a Health IT company formerly known as Wellgistics Health (NASDAQ: WGRX), has completed its stock trading symbol change to “MEDS” on the NASDAQ Capital Market, effective at the start of trading on July 22, 2026, finalizing its corporate rebranding.
DataMEDS focuses on integrating its AI platform EinsteinRx™ and blockchain-enabled PharmacyChain™ into the Health Lives Here app and Tollo Health to support data-driven healthcare, including GLP‑1-associated muscle loss and Long COVID. The company reports 2,847,198 common shares outstanding, with approximately 1,533,930 shares under 90‑day lock-up agreements. There are 919,465 common shares currently in DTCC and available for trading, no debt or preferred securities convertible into common shares, and 80,826 cash warrants outstanding with a fixed exercise price of $35.00 per share.
DataMeds AI (NASDAQ:MEDS), formerly Wellgistics Health (NASDAQ:WGRX), announced completion of its corporate name change and will begin trading under the new ticker MEDS on the NASDAQ Capital Market on July 22, 2026.
The Health IT company integrates its EinsteinRx AI pharmacy dispensing platform with the PharmacyChain blockchain smart contracts system inside the Health Lives Here app. DataMeds plans to build a vertically aligned healthcare ecosystem, initially targeting GLP-1-associated muscle loss and Long COVID, consolidating patient health data on a proprietary blockchain and enabling patient participation in data-transaction revenue.
Wellgistics Health (NASDAQ:WGRX) updated the record date for its previously announced distribution of the Dream Bowl 2026 Meme Coin to stockholders. Holders of Wellgistics common stock as of July 31, 2026 will be entitled to receive 50 Dream Bowl 2026 Meme Coins per share.
Wellgistics will distribute, or work with its transfer agent to distribute, notices and forms to collect stockholders’ digital wallet information so they can receive the coins. The distribution date will be set later by resolution in coordination with Datavault AI (NASDAQ:DVLT). The Dream Bowl 2026 Meme Coin is described as a digital collectible for personal, entertainment and event-access use only, with no equity, voting, dividend, profit-sharing, or monetary rights, and is not intended to be a security or investment.
Wellgistics Health (NASDAQ: WGRX) appointed experienced healthcare IT executive Brett Thompson as consulting Chief Technology Officer, while Srini Kalla stepped down from the CTO role. Thompson brings over 30 years of enterprise software experience, including more than 17 years in healthcare and pharmacy technology.
He is Founder and President of Pivcon, a consulting and software engineering firm, and has led work across cloud-native platforms, interoperability (FHIR, HL7, EDI, SureScripts), AI, cybersecurity, and regulatory compliance. According to the company, Thompson will help implement a direct-to-consumer strategy around the “Health Lives Here” app and support the transition to DataMeds AI.
Wellgistics Health (NASDAQ:WGRX) reported that Executive Chairman Suren Ajjarapu and President & Interim Co-CEO Prashant Patel exercised all previously issued warrants tied to salary-to-share conversions at $10 per share, resulting in 200,000 new common shares.
Following this, Wellgistics has 2,847,198 common shares outstanding, with stockholders holding about 1,533,930 shares under 90-day lock-up agreements, representing a majority of outstanding shares.
Wellgistics Health (NASDAQ:WGRX) plans to change its corporate name to DataMeds AI, subject to shareholder approval, and rebrand its Pharmacy and Pharmacy Services division as Corexa Health. The company reports 2,647,198 common shares outstanding, with a majority under 90-day lock-up and no debt or preferred equity convertible into free-trading common shares.
Wellgistics has a fully binding letter of intent with DataVault AI, EOS Technology Holdings, Scilex Holdings, and HealthBridge Advisors to form DataMeds AI, targeting a vertically integrated healthcare ecosystem built around the Health Lives Here app and EinsteinRx AI platform, with closing anticipated in Q3 2026, subject to conditions.
Wellgistics Health (NASDAQ:WGRX) issued a mid‑year 2026 outlook focused on closing the DelivMeds AI transaction, growing Wellgistics Pharmacy revenue and advancing PharmacyChain™, Medical Drones and Health Lives Here initiatives.
Recent financing and debt restructuring are expected to fund operations into late 2026, with related warrants potentially extending funding through 2029.
A reverse split preserved the NASDAQ listing, while a lock‑up agreement leaves about 1.3 million shares currently tradeable.
Planned milestones include the Health Lives Here app launch and Tollo Health product rollouts in Q3 2026, though DelivMeds AI and QOLPOM deals remain subject to closing conditions.
Wellgistics Health (NASDAQ:WGRX) announced that holders of 1,333,930 common shares, representing a majority of its outstanding common stock, have entered a minimum 90-day lock-up agreement restricting sales into the market.
According to Wellgistics, this, together with recently restructured convertible liabilities and new funding, reflects shareholder confidence in its vertically integrated growth plan.
Wellgistics Health (NASDAQ:WGRX) completed an oversubscribed $21 million convertible debt financing that refinances all existing convertible debt and adds $6.5 million in new capital for working capital and general corporate purposes.
The New Debt bears no interest, converts at $6.00 per share, and may later exchange into Preferred Stock that converts at $50.00 per share, satisfying a capital condition for the DelivMeds AI Transaction.
Wellgistics Health (NASDAQ:WGRX) completed a 1-for-50 reverse stock split of its common shares, effective 12:01 a.m. ET on May 26, 2026. The stock now trades under a new CUSIP.
The split reduced outstanding common shares from about 125,671,251 to approximately 2,513,425 and is intended to raise the share price to help regain compliance with Nasdaq’s minimum bid price requirement. Fractional shares were rounded up to the nearest whole share.